DB00289

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 1994
gptkbp:ATCCode A10BA02
gptkbp:bioavailability 50-60%
gptkbp:brand gptkb:Riomet
gptkb:Glucophage_XR
gptkb:Fortamet
gptkb:Glucophage
gptkb:Glumetza
gptkbp:CASNumber 657-24-9
gptkbp:color white
gptkbp:contraindication metabolic acidosis
renal impairment
gptkbp:drugClass antidiabetic agent
biguanide
gptkbp:excretion renal
gptkbp:form gptkb:tablet
oral solution
gptkbp:halfLife 4-8.7 hours
gptkbp:hasInChIKey gptkb:XZWYZXLIPXDOLR-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C4H11N5
gptkbp:hasSMILES CN(C)C(=N)N=C(N)N
gptkbp:hasUNII 9100L32L2N
https://www.w3.org/2000/01/rdf-schema#label DB00289
gptkbp:includedIn gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:indication gptkb:polycystic_ovary_syndrome
gptkb:type_2_diabetes_mellitus
gptkbp:isApprovedDrug true
gptkbp:legalStatus Rx-only
gptkbp:mechanismOfAction improves insulin sensitivity
decreases hepatic glucose production
decreases intestinal absorption of glucose
gptkbp:metabolism not significantly metabolized
gptkbp:molecularWeight 129.164
gptkbp:name gptkb:Metformin
gptkbp:pregnancyCategory B (US)
gptkbp:proteinBinding negligible
gptkbp:PubChem_CID gptkb:D01841
gptkb:DB00289
6801
4091
3949
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
diarrhea
gastrointestinal upset
lactic acidosis
gptkbp:status true
gptkbp:synonym 1,1-dimethylbiguanide
dimethylbiguanide
gptkbp:target gptkb:AMP-activated_protein_kinase
gptkbp:bfsParent gptkb:atomoxetine
gptkbp:bfsLayer 7